GSK beats third-quarter profit estimates, keeps annual targets
GSK•GSK reported third-quarter core profit of 54.6 pence per share, above analysts’ 50.4-pence expectation, and maintained its annual and long-term targets.
GSK•GSK•GSK•GSK reported third-quarter core profit of 54.6 pence per share, above analysts’ 50.4-pence expectation, and maintained its annual and long-term targets.
GSK’s core profit for the three months ended September 30 was 54.6 pence per share, compared with analysts’ expectation of 50.4 pence. The company also beat third-quarter sales expectations, helped by demand for specialty medicines, and maintained its annual and long-term targets.
